EMOVATE

This brand name is authorized in Austria, Germany, Netherlands, Spain.

Active ingredients

The drug EMOVATE contains one active pharmaceutical ingredient (API):

1
UNII 8U0H6XI6EO - CLOBETASONE BUTYRATE
 

Clobetasone is a topical corticosteroids. Clobetasone has little effect on hypothalamo-pituitary-adrenal function. Clobetasone is less potent than other available corticosteroid preparations and has been shown not to suppress the hypothalamo-pituitary-adrenal axis in patients treated for psoriasis or eczema.
 
Read more about Clobetasone

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
D07AB01 Clobetasone D Dermatologicals → D07 Corticosteroids, dermatological preparations → D07A Corticosteroids, plain → D07AB Corticosteroids, moderately potent (group II)
Discover more medicines within D07AB01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
DE Bundesinstitut für Arzneimittel und Medizinprodukte 12378809
ES Centro de información online de medicamentos de la AEMPS 56273
NL Z-Index G-Standaard 12300713, 12300721
NL Z-Index G-Standaard, PRK 65609, 65617

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈